Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 02, 2026
Why Is Franklin Covey Co. (FC) Stock Down -18% Today?

Why Is Franklin Covey Co. (FC) Stock Down -18% Today?

Key Takeaways

  • Franklin Covey Co. shares plunged roughly -18.17% in after-hours and premarket trading following its fiscal third-quarter 2026 earnings release.
  • The primary catalyst was a cut to full-year fiscal 2026 revenue guidance, even as the company beat quarterly earnings estimates.
  • Secondary pressure came from a decline in gross margin and negative free cash flow for the quarter.
  • The Education Division showed softness tied to state government budget cuts affecting large contracts.
  • Broader market context includes ongoing sensitivity to small-cap consulting and education-services names reporting mixed guidance this earnings season.
  • Traders are watching for management commentary on North America enterprise demand and whether the lowered guidance stabilizes or triggers further estimate cuts.

Opening Summary

Franklin Covey Co. (FC), listed on the NYSE, is a Salt Lake City-based global consulting and training company that helps organizations and individuals improve leadership and organizational performance through its Enterprise and Education divisions. The stock closed the prior regular session at $24.99, up 1.88% on the day, before earnings were released after the closing bell on July 1, 2026. In after-hours and early premarket trading, shares fell to around $20.45, a drop of approximately -18.17% from the prior close. The move confirms a sharp downward reaction, driven primarily by a reduction in the company's fiscal 2026 revenue outlook despite an earnings beat for the quarter.

Earnings Beat Overshadowed by Guidance Cut

Franklin Covey reported third-quarter revenue of $67.8 million, a modest 1% increase year-over-year, alongside adjusted EPS of $0.27, ahead of the $0.24 consensus estimate, and adjusted EBITDA of $8.3 million, up 14% from a year earlier. Net income came in at $3.1 million compared with a net loss of $1.4 million in the same period last year, reflecting improved operational discipline. Despite these headline beats, management revised full-year fiscal 2026 revenue guidance downward to a range of $260 million to $267 million from the previous $265 million to $275 million, even while maintaining adjusted EBITDA guidance of $28 million to $31 million.

Margin Pressure and Cash Flow Concerns

Gross margin for the quarter slipped to 73.9% from 76.5% a year earlier, signaling rising cost pressures relative to revenue. Free cash flow turned negative at roughly -$1 million for the quarter, compared with a positive $2.8 million in the prior-year period, largely due to unfavorable working-capital changes. These metrics added to investor concern that near-term profitability improvements may be harder to sustain even as cost controls continue.

Education Division Softness

The Education Division posted revenue of $19 million, up only slightly, with growth constrained by state government budget cuts that affected several large contracts. This sector-specific headwind mirrors broader challenges facing companies dependent on public education spending, where fiscal tightening at the state level has curbed discretionary program budgets. Subscription revenue within the division did grow 11%, offering a partial offset.

Enterprise Division Resilience

The Enterprise Division, Franklin Covey's larger segment, posted revenue of $48.1 million, a 2% increase, with North America invoiced amounts up 4% to $36.7 million. Deferred revenue rose 7% year-over-year to $96 million, suggesting continued forward demand for subscription-based offerings. This relative strength in the core enterprise business did not offset investor focus on the reduced consolidated outlook.

Market Context and Trading Activity

The scale of the after-hours decline, wiping out nearly a fifth of the stock's value, indicates sharply elevated trading volume relative to typical sessions for this small-cap name. The move appears company-specific rather than sector-wide, tied directly to the earnings and guidance release rather than broader market indices, which were not reported to have moved in tandem. Given the size of the drop, shares are likely testing support levels well below recent trading ranges established prior to the report.

Trending AI Robots

Tickeron's Trending AI Robots page showcases a curated selection of automated trading bots that have demonstrated the strongest recent performance across current market conditions. While Tickeron maintains hundreds of AI-driven trading bots covering thousands of tickers, this page highlights only a subset selected for their relative outperformance. Bots featured vary by strategy type, trading timeframe, historical performance metrics, and the specific symbols they trade, offering a snapshot of algorithmic approaches currently in favor. Investors interested in systematic or bot-assisted trading approaches may find it useful to review the Trending AI Robots page as one input among many in their research process.

What Comes Next for FC

Investors will focus on Franklin Covey's fiscal fourth-quarter and full-year results, expected later in 2026, to see whether the lowered revenue guidance holds or requires further adjustment. Analyst reaction to the guidance cut, including any updated price targets or rating changes in the days following the report, will be closely watched for shifts in sentiment. Continued monitoring of state and federal budget conditions affecting the Education Division, along with enterprise demand trends in North America and internationally, will be key to assessing the trajectory of the business. Risks include further contract cancellations tied to public-sector budget constraints and any additional margin compression, while potential catalysts include stabilization in subscription revenue growth and share repurchase activity, of which the company bought back nearly 1.6 million shares for $28.1 million year to date.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: FC

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


FC in upward trend: price may jump up because it broke its lower Bollinger Band on September 02, 2026

FC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 37 of 50 cases where FC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FC's RSI Oscillator exited the oversold zone, 23 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 62 cases where FC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.

The Moving Average Convergence Divergence (MACD) for FC just turned positive on September 30, 2026. Looking at past instances where FC's MACD turned positive, the stock continued to rise in 29 of 44 cases over the following month. The odds of a continued upward trend are 66%.

Following a +3.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where FC advanced for three days, in 196 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FC as a result. In 69 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.

The 50-day moving average for FC moved below the 200-day moving average on October 01, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

The Aroon Indicator for FC entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 3 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. FC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.458) is normal, around the industry mean (2.806). P/E Ratio (113.000) is within average values for comparable stocks, (48.312). Projected Growth (PEG Ratio) (0.931) is also within normal values, averaging (1.327). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.814) is also within normal values, averaging (27.566).

The Tickeron SMR rating for this company is 84 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

Notable companies

The most notable companies in this group are TAL Education Group (NYSE:TAL).

Industry description

‘Other Consumer Specialties’ represents an industry that typically sells durable consumer products, but do not have a classification in another category. The products include jewelry, smoke detectors, watches, collectibles and safety products. MSA Safety (makes products which enhances the safety and health of workers and protect facility infrastructures), Matthews International (memorialization business), Fitbit (makes wireless-enabled wearable technology devices that gauge data such as the number of steps walked, heart rate, quality of sleep), and Fossil Group (makes watches and accessories) have some of the largest market caps in this group.

Market Cap

The average market capitalization across the Other Consumer Specialties Industry is 1.14B. The market cap for tickers in the group ranges from 90 to 15B. PANDY holds the highest valuation in this group at 15B. The lowest valued company is BSEFY at 90.

High and low price notable news

The average weekly price growth across all stocks in the Other Consumer Specialties Industry was 1%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -16%. JDZG experienced the highest price growth at 15%, while AMBO experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Other Consumer Specialties Industry was 17%. For the same stocks of the Industry, the average monthly volume growth was 50% and the average quarterly volume growth was 19%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 70
Price Growth Rating: 67
SMR Rating: 78
Profit Risk Rating: 86
Seasonality Score: 4 (-100 ... +100)
View a ticker or compare two or three
FC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of training and consulting solutions

Industry OtherConsumerSpecialties

Industry
Miscellaneous Commercial Services
Address
13907 South Minuteman Drive
Phone
+1 801 817-1776
Employees
1120
Web
https://www.franklincovey.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.